Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
LymphomaNonneoplastic Condition
Interventions
GENETIC

DNA analysis

GENETIC

RNA analysis

GENETIC

cytogenetic analysis

GENETIC

in situ hybridization

GENETIC

mutation analysis

GENETIC

polymerase chain reaction

GENETIC

western blotting

OTHER

flow cytometry

OTHER

immunohistochemistry staining method

OTHER

medical chart review

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT01490801 - Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma | Biotech Hunter | Biotech Hunter